These results indicate that changes in the expression of combinations of genes, as opposed to individual genes, may explain the selective inhibitory effects of CPSF1 shRNA knockdown on the growth of prostate cancer cells but not prostate epithelial cells (Figures 2J–2M). The gene discussed is CPSF1; the disease is prostate carcinoma.